2025 (the “Deficiency Letter II”) from Nasdaq notifying that Mynaric is no longer in compliance with Listing Rule 5620(a) due to its failure to hold an annual meeting of shareholders within ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback